Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel

Overview of attention for article published in Frontiers in Pharmacology, May 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 83 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5,838 followers.

Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases… https://t.co/dwKWYPtO9K

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.